11/21
11:15 am
catx
Rating for CATX
Medium
Report
Rating for CATX
10/13
09:56 am
catx
Rating for CATX
Low
Report
Rating for CATX
10/10
06:59 am
catx
Perspective Therapeutics initiated with a Buy at BTIG
High
Report
Perspective Therapeutics initiated with a Buy at BTIG
10/10
06:25 am
catx
Rating for CATX
High
Report
Rating for CATX
10/3
08:08 am
catx
Perspective Therapeutics (NYSE:CATX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Low
Report
Perspective Therapeutics (NYSE:CATX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
10/2
10:29 am
catx
Perspective Therapeutics (NYSE:CATX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Low
Report
Perspective Therapeutics (NYSE:CATX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
10/2
10:29 am
catx
Perspective Therapeutics (NYSE:CATX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Low
Report
Perspective Therapeutics (NYSE:CATX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
9/19
08:07 am
catx
Perspective Therapeutics (NYSE:CATX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Low
Report
Perspective Therapeutics (NYSE:CATX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
9/15
11:03 pm
catx
Perspective Therapeutics (NYSE:CATX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Medium
Report
Perspective Therapeutics (NYSE:CATX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
9/15
11:03 pm
catx
Perspective Therapeutics (NYSE:CATX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.
Medium
Report
Perspective Therapeutics (NYSE:CATX) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $11.00 price target on the stock.